Streamlining the supply chain: insights on raw material sourcing and quality by design

Lara Silverman

19 March 2025

Interview

Regulatory innovations: why is the UK an attractive hub for CGT development?

Rehma Chandaria

13 February 2025

Interview

Pioneering quality control in biomanufacturing of cell and gene therapies

Dhruv Sareen, Jonathan Rodriguez

05 December 2024

Interview

Beyond CRISPR: exploring the next frontier in gene editing technologies

Devyn Smith

18 September 2024

Interview

Advancing CAR-T therapies: navigating innovation, challenges, and the future of biopharma analytics

Adam Fung

09 September 2024

Interview

Considerations to optimize and act upon long-term follow-up studies for cell and gene therapies

E Donahue, L Pelloso, D Takefman et al

26 July 2024

Interview

Exploring analytical assays and CMC challenges for viral vector-based therapies

Vladimir Slepushkin

19 June 2024

Interview

How will recent agency initiatives and likely future directions for regulatory CMC guidance impact the cellular immunotherapy space?

Adeyemi Afuwape

06 June 2024

Interview

Gene therapy is having a monumental year: how can the industry keep up with supply?

Suman Subramanian

04 April 2024

Interview

Quantitative viral vector characterization: prioritizing genome vector integrity

David Dobnik

21 February 2024

Interview

Evolution in the landscape of non-clinical safety testing for advanced therapies

Michaela Sharpe

19 January 2024

Interview

Bringing the Sleeping Beauty transposon system to the clinic

Zoltán Ivics

18 October 2023

Interview

Identifying and leveraging viral vector critical quality attributes & critical process parameters using process analytical technologies

Jonathan Appleby, John Churchwell

24 August 2023

Interview

Key considerations & development of regulatory guidance in CMC

David Ordóñez del Valle

11 April 2023

Interview

Seizing the day: addressing the urgent need for standards development in regenerative medicine

Richard McFarland

15 March 2023

Interview

Navigating the path to clinic for ATMPs: a regulator’s perspective

James W McBlane

02 February 2023

Interview

Inside the UK’s brave new world of ATMP regulatory innovation

Jacqueline Barry

01 August 2022

Interview

Evolving ATMP regulations in the EU & UK, & the role of the Qualified Person

David Caulfield

10 July 2022

Interview

Trends in academic ATMP development & manufacture in Europe

Pauline Meij

10 July 2022

Interview

Regulatory learnings for the next wave of cellular immuno-oncology agents

Robert Pietrusko

26 June 2022

Interview

Cell & gene therapy R&D & regulatory evolution in the United Arab Emirates

Asawari Bapat

24 June 2022

Interview